Stone X Group Inc. Zomedica Corp. Transaction History
Stone X Group Inc.
- $1.14 Billion
- Q3 2024
A detailed history of Stone X Group Inc. transactions in Zomedica Corp. stock. As of the latest transaction made, Stone X Group Inc. holds 20,000 shares of ZOM stock, worth $2,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$2,400
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ZOM
# of Institutions
87Shares Held
80.9MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA48.3MShares$5.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA9.93MShares$1.19 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.86MShares$1.18 Million0.0% of portfolio
-
State Street Corp Boston, MA3.51MShares$421,1850.0% of portfolio
-
Brown Brothers Harriman & CO New York, NY2.47MShares$295,9830.0% of portfolio
About Zomedica Corp.
- Ticker ZOM
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 979,950,016
- Market Cap $118M
- Description
- Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...